Skip to main content

Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.

Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Misoprostol for Bloating and Distension

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Misoprostol for Bloating and Distension

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

PerQseal® Impella Early Feasibility Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about PerQseal® Impella Early Feasibility Study

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 191
  • Page 192
  • Page 193
  • Page 194
  • Page 195
  • Page 196
  • Page 197
  • Page 198
  • Page 199
  • …
  • Next page Next
  • Last page Last
Subscribe to